251 related articles for article (PubMed ID: 16390899)
21. Treatment as usual (TAU) for depression: a comparison of psychotherapy, pharmacotherapy, and combined treatment at a large academic medical center.
Blais MA; Malone JC; Stein MB; Slavin-Mulford J; O'Keefe SM; Renna M; Sinclair SJ
Psychotherapy (Chic); 2013 Mar; 50(1):110-8. PubMed ID: 23505987
[TBL] [Abstract][Full Text] [Related]
22. Quality of care for primary care patients with anxiety disorders.
Stein MB; Sherbourne CD; Craske MG; Means-Christensen A; Bystritsky A; Katon W; Sullivan G; Roy-Byrne PP
Am J Psychiatry; 2004 Dec; 161(12):2230-7. PubMed ID: 15569894
[TBL] [Abstract][Full Text] [Related]
23. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002.
Compton WM; Conway KP; Stinson FS; Grant BF
Am J Psychiatry; 2006 Dec; 163(12):2141-7. PubMed ID: 17151166
[TBL] [Abstract][Full Text] [Related]
24. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders.
Carey TL
Handb Exp Pharmacol; 2019; 250():359-370. PubMed ID: 30244298
[TBL] [Abstract][Full Text] [Related]
25. Do the effects of quality improvement for depression care differ for men and women? Results of a group-level randomized controlled trial.
Sherbourne CD; Weiss R; Duan N; Bird CE; Wells KB
Med Care; 2004 Dec; 42(12):1186-93. PubMed ID: 15550798
[TBL] [Abstract][Full Text] [Related]
26. The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trial.
Gold AK; Peters AT; Otto MW; Sylvia LG; Magalhaes PVDS; Berk M; Dougherty DD; Miklowitz DJ; Frank E; Nierenberg AA; Deckersbach T
Aust N Z J Psychiatry; 2018 Sep; 52(9):847-855. PubMed ID: 30047784
[TBL] [Abstract][Full Text] [Related]
27. Achieving abstinence by treating depression in the presence of substance-use disorders.
Hesse M
Addict Behav; 2004 Aug; 29(6):1137-41. PubMed ID: 15236814
[TBL] [Abstract][Full Text] [Related]
28. Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study: design and practical implications of an intervention for comorbid pain and depression.
Kroenke K; Bair M; Damush T; Hoke S; Nicholas G; Kempf C; Huffman M; Wu J; Sutherland J
Gen Hosp Psychiatry; 2007; 29(6):506-17. PubMed ID: 18022044
[TBL] [Abstract][Full Text] [Related]
29. Major depression: the importance of clinical characteristics and treatment response to prognosis.
Katon W; Unützer J; Russo J
Depress Anxiety; 2010; 27(1):19-26. PubMed ID: 19798766
[TBL] [Abstract][Full Text] [Related]
30. Psychotherapy utilization for acute depression within the Veterans Affairs health care system.
Burnett-Zeigler IE; Pfeiffer P; Zivin K; Glass JE; Ilgen MA; Flynn HA; Austin K; Chermack ST
Psychol Serv; 2012 Nov; 9(4):325-35. PubMed ID: 22564035
[TBL] [Abstract][Full Text] [Related]
31. Benchmarking the effectiveness of psychotherapy treatment for adult depression in a managed care environment: a preliminary study.
Minami T; Wampold BE; Serlin RC; Hamilton EG; Brown GS; Kircher JC
J Consult Clin Psychol; 2008 Feb; 76(1):116-24. PubMed ID: 18229989
[TBL] [Abstract][Full Text] [Related]
32. Usual care psychotherapy for depression in a large managed behavioral health organization.
Hepner KA; Greenwood GL; Azocar F; Miranda J; Burnam MA
Adm Policy Ment Health; 2010 May; 37(3):270-8. PubMed ID: 19859800
[TBL] [Abstract][Full Text] [Related]
33. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
Horsfall J; Cleary M; Hunt GE; Walter G
Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales.
Frisher M; Collins J; Millson D; Crome I; Croft P
J Epidemiol Community Health; 2004 Dec; 58(12):1036-41. PubMed ID: 15547069
[TBL] [Abstract][Full Text] [Related]
35. Impact of PTSD comorbidity on one-year outcomes in a depression trial.
Green BL; Krupnick JL; Chung J; Siddique J; Krause ED; Revicki D; Frank L; Miranda J
J Clin Psychol; 2006 Jul; 62(7):815-35. PubMed ID: 16703602
[TBL] [Abstract][Full Text] [Related]
36. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
[TBL] [Abstract][Full Text] [Related]
37. Improving care for minorities: can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial.
Miranda J; Duan N; Sherbourne C; Schoenbaum M; Lagomasino I; Jackson-Triche M; Wells KB
Health Serv Res; 2003 Apr; 38(2):613-30. PubMed ID: 12785564
[TBL] [Abstract][Full Text] [Related]
38. Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
Coughlin LN; Pfeiffer P; Ganoczy D; Lin LA
Am J Psychiatry; 2021 May; 178(5):414-423. PubMed ID: 33115247
[TBL] [Abstract][Full Text] [Related]
39. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.
Mittal D; Fortney JC; Pyne JM; Wetherell JL
J Clin Psychiatry; 2011 Nov; 72(11):1445-51. PubMed ID: 21208594
[TBL] [Abstract][Full Text] [Related]
40. Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.
Ostacher MJ
Psychiatr Clin North Am; 2007 Mar; 30(1):69-76. PubMed ID: 17362804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
